Ascend Wellness Holdings (AAWH) Depreciation and Depletion (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Depreciation and Depletion came in at $12.5 million in Q1 2026, up 27.13% year-on-year from $9.9 million in Q1 2025, and up 9.24% quarter-over-quarter from $11.5 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Depreciation and Depletion (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Depreciation and Depletion history runs 7 years deep, the most recent figure standing at $12.5 million for Q1 2026.
- On a quarterly basis, Depreciation and Depletion rose 27.13% year-over-year to $12.5 million in Q1 2026; TTM through Mar 2026 was $44.2 million, a 17.94% increase from a year earlier, with the FY2025 full-year figure at $41.6 million, up 12.96% from the prior year.
- Depreciation and Depletion advanced to $12.5 million in Q1 2026 per AAWH's latest filing, from $11.5 million in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $12.5 million in Q1 2026 and bottomed at $5.4 million in Q1 2022.
- The 5-year median for Depreciation and Depletion is $9.1 million (2024), against an average of $8.8 million.
- Across the five-year window, Depreciation and Depletion soared 82.24% in 2022 and grew 2.66% in 2024, its largest moves.
- Year by year, Depreciation and Depletion stood at $7.3 million in 2022, then gained by 26.29% to $9.2 million in 2023, then increased by 2.66% to $9.5 million in 2024, then increased by 21.33% to $11.5 million in 2025, then increased by 9.24% to $12.5 million in 2026.
- Per Business Quant, the three latest AAWH Depreciation and Depletion figures stand at $12.5 million (Q1 2026), $11.5 million (Q4 2025), and $10.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 36.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 28.00 Mn |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn | 12.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.54 Mn |
| Mar 31, 2026 | 12.54 Mn |
| Dec 31, 2025 | 11.48 Mn |
| Dec 31, 2025 | 11.48 Mn |
| Sep 30, 2025 | 10.51 Mn |
| Sep 30, 2025 | 10.51 Mn |
| Jun 30, 2025 | 9.72 Mn |
| Jun 30, 2025 | 9.72 Mn |
| Mar 31, 2025 | 9.86 Mn |
| Mar 31, 2025 | 9.86 Mn |
| Dec 31, 2024 | 9.46 Mn |
| Dec 31, 2024 | 9.46 Mn |
| Sep 30, 2024 | 9.06 Mn |
| Sep 30, 2024 | 9.06 Mn |
| Jun 30, 2024 | 9.14 Mn |
| Jun 30, 2024 | 9.14 Mn |
| Mar 31, 2024 | 9.15 Mn |
| Mar 31, 2024 | 9.15 Mn |
| Dec 31, 2023 | 9.21 Mn |
| Dec 31, 2023 | 9.21 Mn |